Login to Your Account

Pharma: Other News To Note

Monday, October 21, 2013
Boehringer Ingelheim GmbH, of Ingelheim, Germany, said that the review process for the marketing authorization application for Striverdi Respimat in the European Union had been completed successfully.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription